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Malaria control is reliant on the use of long-lasting pyrethroid-
impregnated nets and/or indoor residual spraying (IRS) of insecti-
cide. The rapid selection and spread of operationally signiﬁcant
pyrethroid resistance in Africanmalaria vectors threatens our ability
to sustain malaria control. Establishing whether resistance is opera-
tionally signiﬁcant is technically challenging. Routine monitoring by
bioassay is inadequate, and there are limited data linking resistance
selection with changes in disease transmission. The default is to
switch insecticides when resistance is detected, but limited in-
secticide options and resistance to multiple insecticides in numer-
ous locations make this approach unsustainable. Detailed analysis
of the resistance situation in Anopheles gambiae on Bioko Island
after pyrethroid resistance was detected in this species in 2004, and
the IRS program switched to carbamate bendiocarb, has now been
undertaken. The pyrethroid resistance selected is a target-site
knock-down resistance kdr-form, on a background of generally
elevated metabolic activity, compared with insecticide-suscepti-
ble A. gambiae, but the major cytochrome P450-based metabolic
pyrethroid resistance mechanisms are not present. The available
evidence from bioassays and infection data suggests that the pyre-
throid resistance mechanisms in Bioko malaria vectors are not opera-
tionally signiﬁcant, and on this basis, a different, long-lasting
pyrethroid formulation is now being reintroduced for IRS in a rota-
tional insecticide resistance management program. This will allow
control efforts to be sustained in a cost-effective manner while re-
ducing the selection pressure for resistance to nonpyrethroid
insecticides. The methods used provide a template for evi-
dence-based insecticide resistance management by malaria
control programs.
Malaria control activities in Africa have been scaled up duringthe last decade. Disease control is predominantly dependent
on the distribution and use of pyrethroid-impregnated long lasting
insecticide-treated nets (LLINs) and/or indoor residual spraying
(IRS) of insecticides. The choice of insecticides for IRS is currently
limited to four classes with only two modes of action. One of these
insecticide classes, pyrethroids, is also the only class recommended
for use by the World Health Organization (WHO) on LLINs. The
recent rapid selection and spread of pyrethroid resistance in
malaria vectors has stimulated the WHO to develop a Global Plan
for Insecticide Resistance Management (1), encouraging countries
to plan and implement insecticide resistance management strate-
gies and to underpin these strategies with proper, timely entomo-
logical resistance monitoring and effective data management. This
must be implemented in the short term at the same time medium-
to long-term efforts are made to expand the available insecticide
choice (2). To be effective, resistance management plans need
to be closely aligned with local evidence supported by an ef-
fective monitoring system.
Here we detail how this process has been undertaken in
Equatorial Guinea, resulting in a detailed Operational Plan for
Insecticide Resistance Management, which is owned by the Na-
tional Malaria Control Program, Ministry of Health and Social
Welfare, Equatorial Guinea. The plan was formally adopted
in 2012.
Bioko, the main island of Equatorial Guinea, has a population
of ∼200,000 people. It is situated 30 miles off the coast of
Cameroon, experiences high annual rainfall (∼2,000 mm/y), and
has in recent years undergone major economic and infrastructural
development as a result of offshore oil and gas production.
Malaria is endemic, with Entomological Inoculation Rates of 281
and 787 infective bites per year recorded for Anopheles gambiae
and Anopheles funestus, respectively, in 2002 (3), which was before
the scaling-up of malaria control activities. Comprehensive
malaria control interventions were introduced jointly by the Bioko
Island Malaria Control Project (BIMCP) and the Ministry of
Health and Social Welfare in 2004, with the aim of drastically
reducing disease burden and, ultimately, eliminating malaria from
the island. Serological markers suggest heterogeneity of ef-
fectiveness of malaria control activities across the island to date
(4). The BIMCP is funded by a private sector consortium led by
Marathon Oil Company. Malaria vector control, managed by
Medical Care Development International, consists primarily of
IRS of all houses on the island. The ﬁrst round of IRS using a
pyrethroid (deltamethrin) was carried out between March and
July 2004, followed by two rounds per year of bendiocarb
spraying from 2005 onward. In 2007, a mass distribution of
LLINs [PermaNet (Vestergaard Frandsen) 2.0, containing 55
mg/m2 deltamethrin] was undertaken, providing one net per
sleeping area. Although net coverage was initially high, numbers
on the island declined rapidly as nets were redistributed by the
recipient population.
During the ﬁrst round of deltamethrin IRS in 2004, a large
proportion of A. gambiae s.s. mosquitoes sampled from window
exit traps were shown to possess the West African form of the
kdr mutation (leu1014–phe), which confers dichlorodiphenyltri-
chloroethane resistance and a low level of cross-resistance to all
pyrethroids through insecticide target-site insensitivity (5). Pyre-
throid resistance assessed by WHO susceptibility tests and the kdr
mutation were present in both the M and S forms of A. gambiae s.s.
on Bioko. The presence or absence of metabolically conferred
pyrethroid resistance was not assessed at this time, although data
from neighboring Cameroon suggests that this form of pyrethroid
resistance is now widespread in theA. gambiae complex (6, 7). The
detection of pyrethroid resistance, and an apparent lack of re-
sponse to the IRS treatment by A. gambiae compared with A.
funestus, prompted a switch from deltamethrin to a carbamate
insecticide from the second spray round onward. However,
malaria indicator surveys carried out both prespraying in February
to March 2004 and postspraying in the same months in 2005
showed a large reduction in the prevalence of malaria infection
in children aged from 2 to <15 y, going from 46% [95% conﬁ-
dence interval (CI), 40–51%] to 31% [95% CI, 24–40%] (8), in-
dicating that the deltamethrin spray round had a substantial
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epidemiological effect. Routine entomological surveys from 2004
to 2012 suggested that A. funestus had been eliminated or vir-
tually eliminated from Bioko, leaving the vectors A. gambiae s.s.
and Anopheles melas. Subsequent routine bioassays and PCR
analysis for the kdr mutation showed that despite replacement of
deltamethrin with bendiocarb for IRS during a 7-y period, the
frequency of pyrethroid resistance and the kdr mutation remained
high in A. gambiae s.s.
To determine retrospectively whether the presence of the kdr
gene in A. gambiae compromised the operational effectiveness
of deltamethrin IRS in Bioko in 2004, an analysis of ∼4,000
A. gambiae specimens caught in window traps after the spray
round in 2004 was carried out. The aim was to determine whether
sporozoite rates in kdr-positive mosquitoes were higher than in
kdr-negative mosquitoes.
In addition, the poor alignment of kdr positivity with survival
in WHO pyrethroid susceptibility tests suggested that multiple
pyrethroid resistance mechanisms were circulating in the Bioko
population of A. gambiae. Metabolically based resistance mech-
anisms were assessed using microarrays and quantitative (q)PCR
in A. gambiae specimens collected from Bioko in 2011.
The retrospective sporozoite–kdr analysis of the A. gambiae
specimens collected after the pyrethroid spray round in 2004, and
the results of the metabolic resistance testing of A. gambiae sam-
ples collected in 2011, coupled with a reassessment of the mos-
quito density data from 2004 onward, has allowed us to develop an
evidence-based operational resistancemanagement program. This
will underpin cost-effective maintenance of operational IRS ac-
tivity for Equatorial Guinea and serve as a template that other
malaria-endemic countries faced with similar insecticide resistance
issues could follow.
Results and Discussion
Effect of Deltamethrin IRS onMosquito Densities and Sporozoite Rates.
Data presented from window exit trap collections from sentinel
sites in Bioko in 2004–2005 (5) have been widely interpreted as
demonstrating that deltamethrin spraying rapidly controlled the
A. funestus population but was ineffective against the A. gambiae
population (Fig. 1A). We have now disaggregated the window
trap data for A. gambiae (Fig. 1B) to show the actual numbers of
mosquitoes caught pre- and postspray, as households with win-
dow traps were obviously not all sprayed simultaneously on the
ﬁrst day of the spray campaign but, rather, were treated pro-
gressively during the 3-mo treatment cycle, with the last houses
sprayed in early July 2004. This reassessment of these data shows
that deltamethrin had a similar effect on both A. funestus and
A. gambiae, despite the high frequency of the kdr mutation in the
A. gambiae. The average number of A. gambiae caught per trap
per night rose steeply in the ﬁrst half of 2004 in houses that had
not yet been sprayed, in line with normal annual population
density ﬂuctuations linked to rainfall patterns. Collections from
houses that had already been sprayed were substantially lower
(Fig. 1B). Note that the natural peak in A. funestus numbers is
not synchronous with that of A. gambiae, as the former breed in
permanent breeding sites, whereas the latter are more dependent
on transient breeding sites associated with recent rainfall.
Before IRS was initiated, Plasmodium falciparum sporozoite
positivity in A. gambiae was 6% (95% CI, 4.5–7.8%), dropping to
0.4% (95% CI, 0.3–0.5) immediately after spraying of a site, then
rebounding partially to 3.1% (95% CI, 2.5–3.9%) at 6 mo after
spraying of the island (Fig. 2).
Status of Metabolically Based Resistance in A. gambiae. Metaboli-
cally based pyrethroid resistance is increasingly being seen in
A. gambiae and A. funestus from different parts of West Africa (9).
Fig. 1. Numbers of Anopheles caught in domestic
window traps in Bioko in 2004–2005, disaggregated
to show the effect of house spraying. (A) Graph
reproduced from ref. 5. (B) The same data from Sharp
et al., 2007, disaggregated into window-trap nights
prespraying (green) and window trap nights post-
spraying (blue). The spray round was carried out be-
tween February and July 2004.
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To assess whether metabolic resistance is currently an issue in
Bioko, larvae were collected from Malabo, Bioko, in 2011, reared
to 3-d-old adults, and exposed to insecticide, and the survivors
from these exposures were compared with the unexposed controls
from the same collection and with an insecticide-susceptible West
African colony ofA. gambiae. Exposure to theWHOdiscriminating
dosage of deltamethrin (0.05%) for 1 h resulted in 40% mortality,
conﬁrming that the Bioko population retained a high frequency of
resistance to deltamethrin, despite 7 y of bendiocarb IRS. Exposure
to the WHO discriminating dosage of bendiocarb (0.1%) for 1 h
resulted in 100%mortality; hence, the exposure timewas decreased
to 10–15 min, giving 85% mortality to generate survivors for the
microarray comparison. The bioassay data suggest that the Bioko
population, unlike A. gambiae from much of West Africa, remains
susceptible to bendiocarb despite the recent IRS selection pressure
with this insecticide. The carbamate resistance elsewhere in West
African A. gambiae is a result of a mutation in acetylcholinesterase,
the target site for carbamates and organophosphates (10). The
Gly119-Ser mutation in the acetylcholinesterase (ace) gene was
assessed by PCR and was not present in the Bioko population. As
this mutation is present at a high frequency in A. gambiae from
Cameroon, where bendiocarb resistance has been documented
(11), this suggests there is little gene ﬂow between Bioko Island and
the nearest mainland populations. The lack of gene ﬂow is sup-
ported by studies on A. melas. Microsatellite and mitochondrial
DNA analysis of 11 populations showed that this species had a high
degree of genetic differentiation, with populations clustered into
three distinct groups representing Western Africa, Southern
Africa, and Bioko Island. Bayesian clustering provided no evi-
dence for migration from the mainland to Bioko, although the
data indicated that the Bioko and mainland populations were
connected in the past, only becoming isolated during the last
glaciation period (12). A similar study is underway for A. gambiae,
with initial results indicating lower levels of genetic differentiation.
Replicate microarray analysis of insecticide treatment survivors,
compared with unexposed control participants from the same
collections, showed no signiﬁcant differences in gene expression
patterns. Hence, increased bendiocarb or deltamethrin pressure
did not select for individuals with constitutively higher expression
levels of metabolic genes associated with pyrethroid or carbamate
resistance. Such differences would have been anticipated if a ma-
jor metabolically based pyrethroid resistance mechanism was cir-
culating in the Bioko population.
There were signiﬁcant differences between all three Bioko
microarray groups and the insecticide-susceptible Ngusso group
(Fig. 3). Table 1 gives details of the main genes that were differ-
entially expressed. These genes involve a raft of cytochrome P450s,
GSTs, oxidative stress genes, and transporters. The pattern of up-
regulation may reﬂect a general response to the harsher ﬁeld
conditions to which the larvae were exposed compared with the
more controlled insectary conditions encountered by the Ngusso
colony. Alternatively, they may reﬂect normal interstrain variabil-
ity, although the 20–40-fold increases in oxidative stress gene ex-
pression in the ﬁeld populations are outside the normal ranges we
have seen from a large number of different Anopheles populations.
It is notable that themajor cytochrome P450s, Cyp6Z2, Cyp6P3,
Cyp6M2, and Cyp9J32, which metabolize deltamethrin and are
highly up-regulated in strains with very high levels of pyrethroid
resistance in many parts of Africa, are not overexpressed in the
Bioko populations. The pattern of gene up-regulation observed in
the Bioko population may produce a marginal two- to threefold
increase in tolerance to pyrethroids, accounting for the high levels
of survival in theWHO susceptibility assays and lack of correlation
between kdr and susceptibility assay survival, but this is not ex-
pected to produce the 20–100-fold levels of resistance typically
observed in cases of metabolic resistance where operational con-
trol failure is suspected. Hence, this Bioko population resembles
that seen in Kenya (13), rather than those resistant strains found in
Benin, Cameroon, Malawi, Mozambique, and Zambia (14–18).
Effect of kdr on Malaria Transmission. To assess whether mosquitoes
with kdr target site resistance were more likely to be transmitting
malaria, mosquitoes collected in window traps from the sentinel
sites in 2004–2005 were analyzed for molecular form, kdr, and
sporozoite positivity status. A total of 4,619 A. gambiae speci-
mens were tested for P. falciparum, of which 119 (2.6%) were
positive. Of the 4,195 mosquitoes with a valid test for molecular
form of A. gambiae and P. falciparum, 1,495 (36%) were M-
form, of which 2.1% were positive for P. falciparum, whereas
3.3% of the 2,700 S-form mosquitoes were P. falciparum-posi-
tive (Table 2). Of the 3,848 mosquitoes for which both kdr and P.
falciparum results were available, 1,741 (45%) were homozygous
negative for kdr (SS) and 1,564 (41%) were heterozygous for the
kdr mutation, with the remaining 543 (14%) homozygous for
kdr. Of the homozygous non-kdr, heterozygous kdr, and homo-
zygous kdr, 2.4%, 4.4%, and 1.1%, respectively, were sporozo-
ite-positive (Table 2).
As kdr tends to be functionally recessive (19), the insecticide
resistance phenotype of non-kdr and kdr heterozygotes is simi-
lar. Hence, the homozygote non-kdr and heterozygote kdr were
combined into a single category. When the sporozoite-positive
proportions for these combined groups were calculated separately
for each of themolecular forms, sporozoite-positive fractions were
Fig. 2. The sporozoite rates in A. gambiae before and at different time
intervals after spraying.
Fig. 3. Whole-genome reciprocal dye swap pairwise microarray comparisons
of A. gambiae populations collected from Bioko, unexposed or exposed to in-
secticides with a susceptible West African A. gambiae population.
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lower for homozygous kdr than for the combined heterozygous
and homozygous non-kdr group. This was the case both in the
S form [1.2% vs. 3.0%; odds ratio (OR), 0.38; 95% CI, 0.22–0.64;
P = 0.002; Table 2] and in the M form (0.9% vs. 3.5%; OR, 0.25;
95% CI 0.04–1.43; P = 0.11; Table 3). Adjusting for molecular
type, the overall effect of kdr status on sporozoite positivity was
highly signiﬁcant (OR, 0.34; 95% CI, 0.22–0.54; P < 0.001) for
homozygous kdr vs. the combined heterozygous and homozygous
non-kdr group). The effect of S form vs. M form on sporozoite
positivity, adjusted for kdr status, was OR, 1.15 (95% CI, 0.70–
1.89; P = 0.58). There was no evidence that molecular form
modiﬁed the effect of kdr on sporozoite positivity (test for in-
teraction, P = 0.65).
Mosquitoes being homozygous for kdr did not appear to com-
promise vector control. Indeed, given their lower sporozoite
positivity in both M and S forms of A. gambiae, the pyrethroid-
resistant kdr homozygotes may be transmitting less malaria than
their susceptible counterparts. Sporozoite data implicate both
M and S forms in transmission. Kdr heterozygote specimens were
on average more likely to be positive relative to kdr-positive and
kdr-negative homozygote specimens. This may require further in-
vestigation. However, an overall conclusion is that kdr status alone
did not operationally reduce the effectiveness of pyrethroid IRS.
Similarly a multivillage randomized control trial in Cote d’Ivoire
showed that pyrethroid-treated LLIN efﬁcacy was not adversely
affected by kdr (20), although a study in Senegal suggested kdr
had an effect on increased malaria transmission (21).
Table 1. Level of gene up-regulation from comparative microarray analysis in A. gambiae from Bioko compared with the susceptible
Ngusso strain
Transcript ID Description (Blast2GO annotation)
Fold change
Ngusso vs.
nonexposed
Ngusso vs. deltamethrin
survivors
Ngusso vs. bendiocarb
survivors
Detoxiﬁcation genes
AGAP012296-RA CYP9J5: cytochrome P450
monooxygenase
17 7.61
AGAP002113-RB Cytochrome b5 4.00
AGAP005992-RA CYP302A1: cytochrome P450
monooxygenase
3.26 3.59 3.25
AGAP002863-RA COEA6O: carboxylesterase 2.59
AGAP000284-RA Cytochrome P450 2.39 2.21
AGAP002113-RC Cytochrome b5 2.33
AGAP004380-RA Glutathione transferase GSTD12 2.30 2.52 2.35
AGAP002429-RA CYP315A1: cytochrome P450
monooxygenase
2.27 2.22
AGAP005371-RA COEBE2C: carboxylesterase 2.06
AGAP002416-RA CYP4K2: cytochrome P450
monooxygenase
2.01
AGAP002417-RA CYP4AR1: cytochrome P450
monooxygenase
2.68
AGAP002419-RA CYP4D22: cytochrome P450
monooxygenase
3.48 3.80
AGAP004164-RC GSTD1_4: glutathione S-transferase 2.23
AGAP004383 RA GSTD10: glutathione S-transferase 2.97
AGAP007480-RA CYP6AH1: cytochrome P450
monooxygenase
4.59 5.85
AGAP008209-RA CYP6M1: cytochrome P450
monooxygenase
2.54
AGAP012295-RA CYP9L1: cytochrome P450
monooxygenase
10.82
Cuticular genes
AGAP006497-RA CPR134: cuticle protein 3.71
AGAP003385-RA CPR123: cuticle protein 3.20
AGAP003379-RA CPR 117: cuticle protein 3.08
AGAP012795-RA Cuticle protein putative 2.10
AGAP010906-RA CPFL5: cuticular protein 5
from CPFL family
4.28
AGAP010908-RA CPFL7: cuticular protein 7
from CPFL family
2.80
Oxidative stress
AGAP006226-RA Aldehyde oxidase 46.13 41.74 35.40
AGAP011054-RA TPX2: thioredoxin-dependent
peroxidase
21.99 21.63 24.37
ABC transporters
AGAP011518-RA ATP-binding cassette subfamily a
member = ABCA1
4.37 3.51
AGAP010416-RA ABC transporter 2.01
AGAP007504-RA ATP-binding cassette subfamily a member 2.68
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Operational Implications of the Resistance Data. The decision taken
by the BIMCP in 2004 to switch from pyrethroid IRS to carbamate
was a sensible precaution after detecting high levels of kdr alleles
in the A. gambiae population. The high densities of A. gambiae
caught in window traps across the island in 2004 (5) appeared to
conﬁrm a lack of effectiveness of the pyrethroid spray round. In
contrast, IRS, which was the only malaria control intervention in
Bioko in 2004, had an evident epidemiologic effect, as demon-
strated by community prevalence of infection surveys before and
after the ﬁrst round of deltamethrin treatment. Data presented in
this study indicate that disaggregation of mosquito numbers by
whether they were caught in a window trap before or after the
locality in which it was situated was sprayed shows that densities
of A. gambiae were reduced substantially in response to spraying
(Fig. 1B). In addition, the very sharp reduction in sporozoite in-
fectivity seen in A. gambiae mosquitoes caught in the period im-
mediately after spraying at each site conﬁrms the effectiveness of
the IRS vector control intervention. Sporozoite rates subsequently
rebounded, but at lower levels than before spraying (Fig. 2). Re-
placement of deltamethrin with bendiocarb continued to suppress
theA. gambiae population (Fig. 1B). Although there is no evidence
that bendiocarb resistance has been selected after 7 y of spraying,
the continued low levels of malaria transmission, annual cost of
insecticide, and requirement for two spray rounds per year, cou-
pled with the need to introduce good insecticide resistance man-
agement practice, have resulted in a change of policy. In 2013,
a strategy of alternating a longer-lasting pyrethroid formulation,
which requires only a single round of treatment per year with
a carbamate or organophosphate treatment, will be introduced.
This is expected to maintain or enhance levels of disease control at
reduced cost while limiting selection pressure on the insecti-
cide resource.
Ongoing Monitoring Activities.When deltamethrin is reintroduced,
the operational control program will continue to monitor the
insecticide resistance status of the local vector population, using
routine WHO susceptibility assays. Any obvious changes in the
resistance proﬁle will trigger further investigation. The current
program demonstrates the value of using rapid molecular assess-
ment of local Anopheles vector resistance to inform operational
decision making. If programs rely only on bioassay data, as dem-
onstrated in Bioko in 2004, then insecticides may be prematurely
removed from a country’s resistance management portfolio,
further restricting an already limited choice of public health
pesticides.
Although resistance monitoring should ideally be simpliﬁed to
allow ﬁeld personnel to fully assess the problem, with current
technology this is not yet practical. Certain mutations, such as
those conferring target site resistance (e.g., kdr and ace), can be
screened for using simple PCR assays, but unfortunately, reliable
DNAmarkers for the range of metabolic resistance genes that can
be up-regulated are not yet available. Assessment of these requires
RNA analysis via microarrays or qPCR. The use of synergists such
as piperonyl butoxide (PBO) has been suggested as an interme-
diate step between bioassays and microarray analysis. Although
this will give an indication of underlying metabolically based re-
sistance, great care is needed when interpreting synergist data. The
current study shows that the ﬁeld population of A. gambiae from
Bioko has broadly based increased metabolic activity compared
with insecticide-susceptible insects. Preexposure of this ﬁeld strain
to the broad-spectrum synergist PBO before deltamethrin expo-
sure signiﬁcantly increasedmortality inWHO susceptibility assays.
This was expected, given the poor correlation between kdr and
bioassay survival, but the microarray and infection data were still
required to demonstrate that this type of low-level metabolic re-
sistance had little or no operational signiﬁcance.
Materials and Methods
Monitoring of the IRS intervention is based on a system of 18 sentinel sites
distributed around the island. Annual household malaria indicator surveys
have been carried out since 2004. Entomological monitoring commenced in
late 2003 with a system of window exit traps installed at 6 houses in each of
the sentinel sites (5). Exit traps were emptied daily by householders and the
contents preserved in specially prepared bottles, which were collected on
a 28-d cycle. In 2009, the exit trap system was replaced by two weekly light-
trap collections carried out at the sentinel sites because of the reduced
numbers of insects in the traps after 5 y of IRS.
After initial sorting and morphological identiﬁcation, specimens were
shipped to the laboratories of the South African Medical Research Council in
Durban, where a sample was regularly analyzed by PCR to determine species
identiﬁcation, A. gambiae molecular form, genotype mutation (kdr), and
sporozoite status after removal of the abdomen. Results for each specimen
were entered into a database, including date and location of capture, and
residual material was preserved and stored for further subsequent analysis.
To assess the effect of the kdr mutation on the effectiveness of the initial
pyrethroid spray round, all specimens caught before and after the IRS in
2004 were recently analyzed retrospectively and were combined with
specimen results that were obtained at the time.
Table 2. Mosquito characteristics and sporozoite status of specimens caught in exit traps in
Bioko in 2004
Molecular form and kdr status % (N)
Sporozoite rate
% Pf (n) Odds ratio [95% CI]
Total A. gambiae 100 (4,500) 2.6 (119)
Kdr*
Homozygous susceptible (SS), % 45 (1,741) 2.4 (42) 1
Heterozygous (SRw), % 41 (1,564) 4.4 (69) 1.9 [0.91–3.8], P = 0.090
Homozygous resistant (RwRw), % 14 (543) 1.1 (6) 0.45 [0.25–0.83], P = 0.01
Molecular form
M form, % 36 (1,495) 2.1 (31) 1
S form, % 64 (2,700) 3.3 (88) 1.6[0.98–2.6], P = 0.061
*Seven specimens were heterozygous for the east African variant of kdr SRe, and 5 were ReRw (all sporozoite
negative). For 640 specimens, no kdr status was available (all SEs adjusted for between cluster differences).
Table 3. Sporozoite rate by kdr status for M and S molecular
forms of A. gambiae s.s. caught in exit traps in Bioko in 2004
Molecular form
and Kdr-status
Sporozoite rate (Pf),
% [95% CI] (N) Odds ratio [95% CI]
M
SS or SR 3.0 [2.4–3.9] (855) 1
RR 1.2 [0.64–2.1] (430) 0.38 [0.22–0.64], P = 0.002
Overall 2.4 [1.8–3.2] (1,285)
S
SS or SR 3.5 [2.1–5.9] (2,399) 1
RR 0.9 [0.1–7.6] (110) 0.25[0.04–1.43], P = 0.11
Overall 3.4 [2.0–5.9] (2,509)
All SEs adjusted for clustering by sentinel site.
Hemingway et al. PNAS | June 4, 2013 | vol. 110 | no. 23 | 9401
G
EN
ET
IC
S
Data Analysis. For the A. gambiae mosquitoes caught in exit traps, the av-
erage number caught per trap per night for each calendar month was
plotted for those caught before and those caught after spraying of the
sentinel site. Sporozoite rates were calculated for mosquitoes caught pre-
spraying and 0 to <2 mo, 2 to <4 mo, 4 to <6 mo, and 6 mo or longer after
the spray round. Sporozoite rates were also calculated by kdr status (ho-
mozygous kdr, heterozygous kdr, and homozygous non-kdr) and by mo-
lecular form (M or S). As kdr is a functionally recessive trait, to assess the
effect of kdr and molecular form on sporozoite positivity, odds ratios for
mosquitoes being sporozoite-positive were calculated for kdr homozygotes
vs. kdr heterozygote and kdr-negative homozygotes combined, unadjusted,
and adjusted for molecular form, as well as for S form vs. M form, un-
adjusted and adjusted for kdr status, in a logistic regression model. All SEs
were adjusted for clustering by sentinel site.
Microarray Analysis. For microarray analysis, larval A. gambiae were col-
lected in Malabo, Bioko, in 2011 and reared to 3-d-old adults. The pop-
ulation was split into three batches, which were either used as non-
insecticide-exposed controls or exposed to the WHO discriminating dos-
ages (22) of deltamethrin or bendiocarb for 1 h or 10–15 min, respectively.
After exposure, all mosquito batches were held for 24 h with access to
sugar solution before mortality was scored. PBO [4% (vol/vol) papers]
preexposure for 1 h was undertaken in WHO testing kits immediately
before deltamethrin exposure, as described earlier. A control of PBO ex-
posure alone gave 0% mortality.
RNA extractions, cDNA synthesis, and labeling reactions were performed
independently for each biological replicate. Total RNA was extracted from
three replicate batches of 16–17 adult, female, 3-d-old mosquitoes from each
treatment group, using a PicoPure RNA isolation kit (Arcturus) according to
manufacturer’s instructions. Replicates of the insecticide susceptible Ngusso M
form A. gambiae colony were used as a susceptible control. Total RNA quantity
and quality were assessed using a Nanodrop spectrophotometer (Nanodrop
Technologies) before further use. RNA was ampliﬁed using a RiboAmp RNA
ampliﬁcation kit (Arcturus), according to the manufacturer’s instructions.
Ampliﬁed RNAs were checked for quantity and quality by spectrophotometry
and agarose gel electrophoresis. Ampliﬁed RNA was reverse transcribed into
labeled cDNA and hybridized to the array, as previously described (9). Each
comparison was repeated three times with different biological samples. For
each biological replicate, two hybridizations were performed in which the Cy3
and Cy5 labels were swapped between samples; hence, a total of six hybrid-
izations were performed for each comparison. Labeled cDNA from the
unexposed and insecticide survivors from the deltamethrin and bendiocarb
treatments were cohybridized with the laboratory susceptible A. gambiae
population.
Spots that failed tomeet any of the following criteria in either channelwere
rejected: an intensity value of >300, signal-to-noise ratio >3, and greater than
60% of pixel intensity superior to the median of the local background ±2 SD.
Normalization and statistical analyses of the data were performed using the
Limma 1.9 software package for R 2.3.1, available from the CRAN repository
(www.r-project.org). Background-corrected intensities from the red (R, Cy5)
and the green (G, Cy3) channels were transformed to intensity log-ratios (M =
logR/G) and their corresponding geometrical means [A = (logR + log G)/2].
Within each array, M-values were normalized as a function of A, using the
Lowess (23) scatter plot smoothing function and scaled to equalize themedian
absolute value across all arrays to account for technical biases between repli-
cate hybridizations. Mean expression ratios were submitted to a one-sample
Student t test against the baseline value of one (equal gene expression in both
samples) with a multiple testing correction (Benjamini and Hochberg false-
discovery rate) (24). Genes showing both t test P values < 0.001 and ≥ twofold
over- or underexpression were considered differentially expressed between
comparisons. The expression data from these microarray experiments can be
accessed at Vector base (www.vectorbase.org). A ﬁve-way comparison of the
microarray data was undertaken, as shown in Fig. 3.
PCR was undertaken on DNA samples from individual A. gambiae adults
to check for the presence of the Gly119-Ser mutation in the ace gene as de-
scribed in ref. 10.
1. World Health Organization (2012) Global Plan for Insecticide Resistance Management
in Malaria Vectors (World Health Organization, Geneva).
2. Hemingway J, Beaty BJ, Rowland M, Scott TW, Sharp BL (2006) The Innovative Vector
Control Consortium: Improved control of mosquito-borne diseases. Trends Parasitol
22(7):308–312.
3. Cano J, et al. (2004) Malaria vectors in the Bioko Island (Equatorial Guinea): Esti-
mation of vector dynamics and transmission intensities. J Med Entomol 41(2):
158–161.
4. Cook J, et al. (2011) Serological markers suggest heterogeneity of effectiveness of
malaria control interventions on Bioko Island, equatorial Guinea. PLoS ONE 6(9):
e25137.
5. Sharp B, et al. (2007) Malaria control by indoor residual spraying on the tropical island
of Bioko, Equatorial Guinea. Malar J 6:52, 10.1186/1475-2875-6-52.
6. Etang J, et al. (2003) Insecticide susceptibility status of Anopheles gambiae s.l. (Dip-
tera: Culicidae) in the Republic of Cameroon. J Med Entomol 40(4):491–497.
7. Wondji CS, et al. (2005) Impact of insecticide-treated bed nets implementation on the
genetic structure of Anopheles arabiensis in an area of irrigated rice ﬁelds in the
Sahelian region of Cameroon. Mol Ecol 14(12):3683–3693.
8. Kleinschmidt I, et al. (2006) Reduction in infection with Plasmodium falciparum one
year after the introduction of malaria control interventions on Bioko Island, Equa-
torial Guinea. Am J Trop Med Hyg 74(6):972–978.
9. Ranson H, et al. (2011) Pyrethroid resistance in African anopheline mosquitoes: What
are the implications for malaria control? Trends Parasitol 27(2):91–98.
10. Djogbénou L, et al. (2008) Identiﬁcation and geographic distribution of the ACE-1R
mutation in the malaria vector Anopheles gambiae in south-western Burkina Faso,
West Africa. Am J Trop Med Hyg 78(2):298–302.
11. Antonio-Nkondjio C, et al. (2011) Anopheles gambiae distribution and insecticide
resistance in the cities of Douala and Yaoundé (Cameroon): Inﬂuence of urban ag-
riculture and pollution. Malar J 10:154, 10.1186/1475-2875-10-154.
12. Deitz KC, et al. (2012) Genetic isolation within the malaria mosquito Anopheles
melas. Mol Ecol 21(18):4498–4513.
13. Ranson H, et al. (2004) Genetic mapping of genes conferring permethrin resistance in
the malaria vector, Anopheles gambiae. Insect Mol Biol 13(4):379–386.
14. Wondji CS, et al. (2012) Impact of pyrethroid resistance on operational malaria con-
trol in Malawi. Proc Natl Acad Sci USA 109(47):19063–19070.
15. Djouaka RF, et al. (2008) Expression of the cytochrome P450s, CYP6P3 and CYP6M2
are signiﬁcantly elevated in multiple pyrethroid resistant populations of Anopheles
gambiae s.s. from Southern Benin and Nigeria. BMC Genomics. 2008;9:538.
16. Müller P, et al. (2008) Field-caught permethrin-resistant Anopheles gambiae over-
express CYP6P3, a P450 that metabolises pyrethroids. PLoS Genet 4(11):e1000286.
17. Chanda E, et al. (2011) Insecticide resistance and the future of malaria control in
Zambia. PLoS ONE 6(9):e24336, 10.1371/journal.pone.0024336.
18. Stevenson BJ, et al. (2011) Cytochrome P450 6M2 from the malaria vector Anopheles
gambiae metabolizes pyrethroids: Sequential metabolism of deltamethrin revealed.
Insect Biochem Mol Biol 41(7):492–502.
19. Hemingway J, Hawkes NJ, McCarroll L, Ranson H (2004) The molecular basis of in-
secticide resistance in mosquitoes. Insect Biochem Mol Biol 34(7):653–665.
20. Henry MC, et al. (2005) Protective efﬁcacy of lambda-cyhalothrin treated nets in
Anopheles gambiae pyrethroid resistance areas of Côte d’Ivoire. Am J Trop Med Hyg
73(5):859–864.
21. Trape JF, et al. (2011) Malaria morbidity and pyrethroid resistance after the in-
troduction of insecticide-treated bednets and artemisinin-based combination thera-
pies: A longitudinal study Lancet Inf. Diseases 11(12):925–932.
22. World Health Organization (1998). Test procedures for insecticide resistance
(WHO\CDS\CPC\MAL\98.12) Available at www.who.int/whopes/resistance/en/.
23. Clevel WS, Devlin SJ (1988) Locally Weighted Regression: An Approach to Regression
Analysis by Local Fitting. J Am Stat Assoc 83(403):596–610.
24. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and
powerful approach to multiple testing. J R Stat Soc B 57:289–300.
9402 | www.pnas.org/cgi/doi/10.1073/pnas.1307656110 Hemingway et al.
